Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06629623
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
None
First Post:
2024-09-20
Brief Title:
Current Status of Diagnosis Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Current Status of Diagnosis Treatment and Quality of Life for Patients with Idiopathic Pulmonary Fibrosis
Status:
ENROLLING_BY_INVITATION
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IPFLife
Brief Summary:
The goal of this observational study is to explore current status of diagnosis treatment and quality of life for patients with idiopathic pulmonary fibrosis It aims to integrate qualitative and quantitative data to describe the distribution of perspective experience patient journey treatment expectation and quality of life for patients with idiopathic pulmonary fibrosis
Participants will be invited to participate the interview and answer quantitative survey questions about their quality of life
Participants will be invited to participate the interview and answer quantitative survey questions about their quality of life
Detailed Description:
Idiopathic pulmonary fibrosis IPF is a rare progressive fibrotic interstitial lung disease of unknown aetiology primarily affecting middle-aged and elderly patients more men than women Median survival is 35 years from the time of diagnosis The prognosis is worse than for most common malignancies However patients experiences quality of life and needs during the disease course have not been adequately investigated which leads a lack of evidence to support the priority of treatment or drug development
This study plans to conduct an mixed methods research to integrate qualitative and quantitative data to explore the perspective experience patient journey treatment expectation and quality of life for patients with idiopathic pulmonary fibrosis For qualitative interview there are 50 patients with idiopathic pulmonary fibrosis and 15 physicians will be interviewed For quantitative survey there are 245 patients with idiopathic pulmonary fibrosis will be involved
This study plans to conduct an mixed methods research to integrate qualitative and quantitative data to explore the perspective experience patient journey treatment expectation and quality of life for patients with idiopathic pulmonary fibrosis For qualitative interview there are 50 patients with idiopathic pulmonary fibrosis and 15 physicians will be interviewed For quantitative survey there are 245 patients with idiopathic pulmonary fibrosis will be involved
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None